MPXOF (MPX International) 14-Day RSI: 92.02 (As of Jun. 30, 2026)


What is MPX International 14-Day RSI?

MPX International MPXOF -99.00% 14-Day RSI is 92.02 as of Jun. 30, 2026.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2026-06-30), MPX International's 14-Day RSI is 92.02.

The industry rank for MPX International's 14-Day RSI or its related term are showing as below:

MPXOF's 14-Day RSI is not ranked
in the Drug Manufacturers industry.
Industry Median: 43.745 vs MPXOF: 92.02

MPX International  (OTCPK:MPXOF) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.

MPX International 14-Day RSI Related Terms

MPXOF vs ZTS, CTLT, VTRS: 14-Day RSI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, MPX International's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MPX International 14-Day RSI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MPX International's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where MPX International's 14-Day RSI falls into.


MPX International  (OTCPK:MPXOF) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100–[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 14-Day RSI →
What does a 14-Day RSI of 92.02 mean?
MPX International (MPXOF) has a 14-Day RSI of 92.02 as of Jun. 30, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on MPX International and its competitors.
Is MPX International's 14-Day RSI too high?
MPX International's current 14-Day RSI is 92.02. The Drug Manufacturers industry median 14-Day RSI is 43.75. MPX International's value of 92.02 is 110.4% above this industry median.
How does MPX International's 14-Day RSI compare to ZTS and CTLT?
MPX International's 14-Day RSI of 92.02 can be compared against companies in the Drug Manufacturers industry. The industry median 14-Day RSI is 43.75. MPX International's value of 92.02 is 110.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Drug Manufacturers company?
The median 14-Day RSI among Drug Manufacturers companies is 43.75, based on 1,046 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MPX International's current 14-Day RSI of 92.02 is 110.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on MPX International and its competitors. For the Drug Manufacturers industry, the median 14-Day RSI is 43.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MPX International's current 14-Day RSI is 92.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MPX International stock overvalued right now?
MPX International (MPXOF) has a current 14-Day RSI of 92.02. The current 14-Day RSI is 92.02 and 110.4% above the Drug Manufacturers industry median of 43.75. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For MPX International (MPXOF), the current 14-Day RSI is 92.02 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MPX International Business Description

Address 5255 Yonge Street, Suite 701, Toronto, ON, CAN, M2N 6P4
MPX International Corp is a diversified cannabis company focused on developing and operating assets across the global medical and adult use and engaged in cultivating, manufacturing and marketing products that include cannabinoids as their primary active ingredient. The firm is organized into three segments: Canada, Europe/Africa, and Asia-Pacific. The Canada operating segment's principal business activities consist of production and sale of cannabis, video learning and engagement, patient counselling and referral services. The Europe/Africa operating segment's consist of the production and sale of cannabis and hemp-related products. The Asia-Pacific consist of the production and sale of cannabis. The majority of the revenue is generated in Canada.